HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Song Xu Selected Research

4- (4- cyano- 2- (2- (4- fluoronaphthalen- 1- yl)propionylamino)phenyl)butyric acid

9/2014An EP4 antagonist ONO-AE3-208 suppresses cell invasion, migration, and metastasis of prostate cancer.
8/2014[Inhibitory effect of ONO-AE3-208 on the formation of bone metastasis of prostate cancer in mice].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Song Xu Research Topics

Disease

49Neoplasms (Cancer)
07/2022 - 06/2008
15Lung Neoplasms (Lung Cancer)
01/2022 - 10/2014
13Prostatic Neoplasms (Prostate Cancer)
01/2018 - 11/2007
9Neoplasm Metastasis (Metastasis)
01/2022 - 08/2012
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2016
8Stomach Neoplasms (Stomach Cancer)
09/2021 - 06/2012
7Adenocarcinoma of Lung
06/2021 - 01/2015
6Inflammation (Inflammations)
06/2021 - 09/2014
6Tuberous Sclerosis (Bourneville's Disease)
10/2018 - 11/2012
5Carcinoma (Carcinomatosis)
01/2020 - 01/2015
4Infections
01/2022 - 01/2015
4Carcinogenesis
03/2021 - 01/2013
4Neuroinflammatory Diseases
01/2018 - 01/2013
4Multiple Myeloma
09/2013 - 02/2012
3Carcinoid Tumor (Carcinoid)
12/2022 - 03/2020
3Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 03/2016
3Heart Arrest (Cardiac Arrest)
03/2020 - 01/2019
3Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
11/2019 - 10/2008
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2019 - 01/2018
3Thrombosis (Thrombus)
01/2019 - 03/2018
3Osteoarthritis
12/2018 - 01/2018
3Hepatocellular Carcinoma (Hepatoma)
06/2018 - 10/2015
3Alzheimer Disease (Alzheimer's Disease)
01/2018 - 08/2011
3Insulin Resistance
01/2013 - 08/2011
2Disease Progression
06/2022 - 11/2017
2Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 05/2020
2Breast Neoplasms (Breast Cancer)
03/2021 - 11/2012
2Lymphatic Metastasis
01/2021 - 12/2016
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 07/2015
2Asphyxia (Suffocation)
03/2020 - 01/2019
2Prostatitis
06/2019 - 10/2018
2Acute Kidney Injury (Acute Renal Failure)
12/2018 - 10/2018
2Tuberous Sclerosis 1
12/2018 - 08/2015
2Hemolysis
04/2018 - 01/2017
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2018 - 10/2016
2Gliosis
01/2018 - 01/2017
2Hypoxia (Hypoxemia)
09/2013 - 11/2012
2Glioma (Gliomas)
03/2010 - 06/2008

Drug/Important Bio-Agent (IBA)

13Biomarkers (Surrogate Marker)IBA
09/2021 - 01/2015
13Proteins (Proteins, Gene)FDA Link
06/2021 - 06/2008
9Biological ProductsIBA
01/2021 - 01/2013
7MicroRNAs (MicroRNA)IBA
01/2021 - 06/2012
7Mechanistic Target of Rapamycin Complex 1IBA
10/2018 - 11/2012
4Long Noncoding RNAIBA
03/2021 - 07/2016
3Messenger RNA (mRNA)IBA
06/2022 - 09/2014
3LipopolysaccharidesIBA
01/2022 - 09/2014
3RNA (Ribonucleic Acid)IBA
05/2021 - 01/2020
3B7-H1 AntigenIBA
03/2021 - 01/2021
3Immune Checkpoint InhibitorsIBA
03/2021 - 01/2020
3EnzymesIBA
03/2020 - 02/2017
3LycopeneIBA
12/2019 - 01/2019
3FlavonoidsIBA
05/2019 - 01/2018
3CytokinesIBA
12/2018 - 01/2013
3Peptides (Polypeptides)IBA
01/2018 - 08/2011
3ErbB Receptors (EGF Receptor)IBA
11/2017 - 01/2015
3Tyrosine Kinase InhibitorsIBA
11/2017 - 01/2015
3DNA (Deoxyribonucleic Acid)IBA
01/2016 - 11/2008
2alectinibIBA
06/2022 - 04/2021
2CrizotinibIBA
10/2021 - 04/2021
2Indicators and Reagents (Reagents)IBA
03/2021 - 06/2019
2LigandsIBA
01/2021 - 01/2018
2Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021 - 06/2018
2ImmunosorbentsIBA
03/2020 - 02/2017
2salicylhydroxamic acid (SHAM)IBA
03/2020 - 01/2019
2Mitochondrial Proteins (Mitochondrial Protein)IBA
01/2020 - 01/2019
2Pharmaceutical PreparationsIBA
03/2019 - 10/2016
2AntigensIBA
01/2019 - 12/2016
2Interleukin-6 (Interleukin 6)IBA
12/2018 - 11/2015
2TOR Serine-Threonine KinasesIBA
12/2018 - 11/2012
2Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2018 - 08/2009
2Amyloid (Amyloid Fibrils)IBA
01/2018 - 08/2011
2Ethanol (Ethyl Alcohol)IBA
01/2018 - 01/2018
2Sirolimus (Rapamycin)FDA Link
01/2018 - 01/2017
2Matrix Metalloproteinases (MMPs)IBA
01/2018 - 06/2008
2Dinoprostone (PGE2)FDA Link
01/2018 - 09/2014
2AntioxidantsIBA
01/2018 - 01/2013
2Monomeric GTP-Binding ProteinsIBA
01/2018 - 01/2017
2TensinsIBA
11/2017 - 10/2016
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
11/2017 - 10/2016
2Phosphotransferases (Kinase)IBA
12/2016 - 07/2015
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2015 - 11/2012
24- (4- cyano- 2- (2- (4- fluoronaphthalen- 1- yl)propionylamino)phenyl)butyric acidIBA
09/2014 - 08/2014
2VorinostatFDA Link
12/2013 - 05/2013
2Pioglitazone (Actos)FDA Link
01/2013 - 08/2011
2FructoseIBA
01/2013 - 08/2011
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
02/2012 - 06/2011
2Insulin (Novolin)FDA Link
08/2011 - 03/2004
2matrigelIBA
03/2010 - 06/2008
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
11/2008 - 06/2008
17- chloro- 8- hydroxy- 1- (3'- iodophenyl)- 3- methyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepine (TISCH)IBA
06/2022
1ceritinibIBA
06/2022

Therapy/Procedure

15Therapeutics
06/2022 - 03/2004
5Drug Therapy (Chemotherapy)
01/2022 - 07/2008
4Immunotherapy
06/2021 - 07/2008
3Cardiopulmonary Resuscitation (CPR)
03/2020 - 01/2019
2Neoadjuvant Therapy
01/2022 - 10/2021
2Resuscitation
03/2020 - 03/2019
2Castration
12/2014 - 09/2014
1Operative Surgical Procedures
12/2022
1Segmental Mastectomy (Lumpectomy)
07/2022